ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
209.63
+8.53 (4.24%)
At close: Jul 2, 2026, 4:00 PM EDT
209.06
-0.57 (-0.27%)
After-hours: Jul 2, 2026, 7:13 PM EDT

ResMed Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
30,23737,76728,12032,13430,69235,905
Market Cap Growth
-17.54%34.31%-12.49%4.70%-14.52%28.67%
Enterprise Value
29,42037,41028,75533,48631,33636,404
Last Close Price
209.63258.00191.42218.50209.63246.52
PE Ratio
20.2127.1327.6635.8839.5576.09
Forward PE
17.6825.3222.8630.8234.1045.81
PEG Ratio
1.251.651.542.392.453.30
PS Ratio
5.467.346.007.618.5811.23
PB Ratio
4.686.335.787.789.1312.44
P/TBV Ratio
10.1615.4818.3939.9128.5963.88
P/FCF Ratio
17.2422.7321.6056.02141.8956.63
P/OCF Ratio
16.0021.5620.0746.3587.4148.74
EV/Sales Ratio
5.317.276.147.938.7611.39
EV/EBITDA Ratio
13.8819.4718.7225.1926.2433.24
EV/EBIT Ratio
15.2822.2021.7929.5831.3340.28
EV/FCF Ratio
16.7722.5122.0958.38144.8657.42
Debt / Equity Ratio
0.130.140.170.380.270.27
Debt / EBITDA Ratio
0.390.440.571.190.770.73
Debt / FCF Ratio
0.480.510.672.754.241.25
Net Debt / Equity Ratio
-0.13-0.060.130.330.190.17
Net Debt / EBITDA Ratio
-0.38-0.190.411.020.540.46
Net Debt / FCF Ratio
-0.47-0.210.492.362.980.79
Asset Turnover
0.640.680.690.710.730.69
Inventory Turnover
2.322.392.232.142.593.11
Quick Ratio
1.972.111.181.231.231.00
Current Ratio
3.013.442.593.122.801.73
Return on Equity (ROE)
23.72%25.86%22.70%23.96%24.96%17.63%
Return on Assets (ROA)
17.48%18.70%15.64%15.57%16.53%10.42%
Return on Invested Capital (ROIC)
26.45%25.33%19.40%19.44%21.97%14.45%
Return on Capital Employed (ROCE)
25.77%25.70%22.08%21.77%24.33%23.17%
Earnings Yield
5.03%3.69%3.62%2.79%2.53%1.31%
FCF Yield
5.80%4.40%4.63%1.79%0.70%1.77%
Dividend Yield
1.14%0.82%1.00%0.81%0.80%0.63%
Payout Ratio
23.14%22.19%27.65%28.78%31.48%47.78%
Buyback Yield / Dilution
0.62%0.14%-0.06%-0.28%-0.40%-0.55%
Total Shareholder Return
1.77%0.96%0.94%0.53%0.40%0.08%
SEC Filings: 10-K · 10-Q